All the news Showing 10 of 26 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Temporary Decline in CD4 T-Cell Count After Hepatitis C Infection in PLWHIV Infectious Disease Advisor / 09 January 2019 Eliminating Hepatitis: A unique opportunity that shouldn't be missed The Parliament Magazine / 22 November 2018 Vosevi safe, effective in ‘triple-infected’ patients with HCV, HBV, HIV Healio / 15 October 2018 How Well Do Docs Manage Potential Conflicts Between Hep C and HIV Meds? Manual Items / 10 April 2018 Gilead Sciences Announces FDA Approves Expanded Labeling for Epclusa Gilead press release / 02 August 2017 Targeting MSM with HIV: Treatment as Prevention in the Netherlands Healio Hepatology / 18 July 2017 Differing perspectives on antiviral treatment efficacy in patients co-infected with HIV and HCV EASL press release / 13 April 2016 More than 2 million people co-infected with HIV and hepatitis C Manual Items / 08 March 2016 U.S. FDA Approves Expanded Use of Bristol-Myers Squibb’s Daklinza (daclatasvir) for Additional Challenging-to-treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C Bristol-Myers Squibb press release / 08 February 2016 European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV Bristol-Myers Squibb press release / 01 February 2016 ← First123Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive